Advertisement
Screener

Q/C Technologies, Inc. (QCLS) Income Tax Expense

2.8 / 5 stars · 68/120 Roast Me

Q/C Technologies, Inc. Income Tax Expense

Q/C Technologies, Inc. (QCLS) reported Income Tax Expense of -$269.34 thousand for the 12-month period ending 2015-12-31, per its 10-K filed 2017-04-11.

Discontinued › Expense Statement › Income Tax

us-gaap:IncomeTaxExpenseBenefit · last filed 2017-04-11

  • Q/C Technologies, Inc. income tax expense (benefit) for the quarter ending 2014-09-30 was $0.00.
  • Q/C Technologies, Inc. income tax expense (benefit) for the quarter ending 2014-06-30 was $0.00.
  • Q/C Technologies, Inc. income tax expense (benefit) for the quarter ending 2014-03-31 was $0.00.
  • Q/C Technologies, Inc. income tax expense (benefit) for the quarter ending 2013-09-30 was $0.00.
  • Q/C Technologies, Inc. income tax expense (benefit) for fiscal 2015 was -$269.34K.
Period endIncome Tax Expense (Benefit) 3 monthIncome Tax Expense (Benefit) 6 monthIncome Tax Expense (Benefit) 9 monthIncome Tax Expense (Benefit) 12 month
2015-12-31-$269.34K
10-K · filed 2017-04-11
2014-09-30$0.00
10-Q · filed 2014-11-13
$0.00
derived: sum of 2 quarters · filed 2014-11-13
$0.00
10-Q · filed 2014-11-13
2014-06-30$0.00
10-Q · filed 2014-08-12
$0.00
10-Q · filed 2014-08-12
2014-03-31$0.00
10-Q · filed 2014-05-14
2013-09-30$0.00
10-Q · filed 2014-11-13
$0.00
derived: sum of 2 quarters · filed 2014-11-13
$0.00
10-Q · filed 2014-11-13
2013-06-30$0.00
10-Q · filed 2014-08-12
$0.00
10-Q · filed 2014-08-12
2013-03-31$0.00
10-Q · filed 2014-05-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
Cardio Diagnostics Holdings, Inc. (CDIO)United States$0.006B
BIOMERICA INC (BMRA)United States$0.011B
VOLITIONRX LTD (VNRX)$0.003B-0.64
IMMUCELL CORP /DE/ (ICCC)United States$0.091B116.10
Insight Molecular Diagnostics Inc. (IMDX)United States$0.129B-3.90
MYRIAD GENETICS INC (MYGN)United States$0.397B-4.84
Alpha Teknova, Inc. (TKNO)United States$0.500B-18.12
QuidelOrtho Corp (QDEL)United States$0.733B-0.90
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92